Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
cancer survivor
New digital tool in Australia helps patients manage fear of cancer recurrence
By
Adam Ang
|
04:26 am |
August 16, 2022
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.